-
Something wrong with this record ?
Development of versatile and potent monoquaternary reactivators of acetylcholinesterase
L. Gorecki, V. Hepnarova, JZ. Karasova, M. Hrabinova, C. Courageux, J. Dias, T. Kucera, T. Kobrlova, L. Muckova, L. Prchal, D. Malinak, D. Jun, K. Musilek, F. Worek, F. Nachon, O. Soukup, J. Korabecny
Language English Country Germany
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
ProQuest Central
from 2002-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2000-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 2002-01-01 to 1 year ago
Public Health Database (ProQuest)
from 2002-01-01 to 1 year ago
- MeSH
- Acetylcholinesterase drug effects metabolism MeSH
- Antidotes chemical synthesis chemistry pharmacology MeSH
- Mice, Inbred BALB C MeSH
- Mice MeSH
- Oximes chemical synthesis chemistry pharmacology MeSH
- Cholinesterase Reactivators chemical synthesis chemistry pharmacology MeSH
- Molecular Dynamics Simulation MeSH
- Structure-Activity Relationship MeSH
- Animals MeSH
- Check Tag
- Male MeSH
- Mice MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
To date, the only treatments developed for poisoning by organophosphorus compounds, the most toxic chemical weapons of mass destruction, have exhibited limited efficacy and versatility. The available causal antidotes are based on reactivation of the enzyme acetylcholinesterase (AChE), which is rapidly and pseudo-irreversibly inhibited by these agents. In this study, we developed a novel series of monoquaternary reactivators combining permanently charged moieties tethered to position 6- of 3-hydroxypyridine-2-aldoxime reactivating subunit. Highlighted representatives (21, 24, and 27; also coded as K1371, K1374, and K1375, respectively) that contained 1-phenylisoquinolinium, 7-amino-1-phenylisoquinolinium and 4-carbamoylpyridinium moieties as peripheral anionic site ligands, respectively, showed efficacy superior or comparable to that of the clinically used standards. More importantly, these reactivators exhibited wide-spectrum efficacy and were minutely investigated via determination of their reactivation kinetics in parallel with molecular dynamics simulations to study their mechanisms of reactivation of the tabun-inhibited AChE conjugate. To further confirm the potential applicability of these candidates, a mouse in vivo assay was conducted. While K1375 had the lowest acute toxicity and the most suitable pharmacokinetic profile, the oxime K1374 with delayed elimination half-life was the most effective in ameliorating the signs of tabun toxicity. Moreover, both in vitro and in vivo, the versatility of the agents was substantially superior to that of clinically used standards. Their high efficacy and broad-spectrum capability make K1374 and K1375 promising candidates that should be further investigated for their potential as nerve agents and insecticide antidotes.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004561
- 003
- CZ-PrNML
- 005
- 20221024101853.0
- 007
- ta
- 008
- 220113s2021 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00204-021-02981-w $2 doi
- 035 __
- $a (PubMed)33517499
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Gorecki, Lukas $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic
- 245 10
- $a Development of versatile and potent monoquaternary reactivators of acetylcholinesterase / $c L. Gorecki, V. Hepnarova, JZ. Karasova, M. Hrabinova, C. Courageux, J. Dias, T. Kucera, T. Kobrlova, L. Muckova, L. Prchal, D. Malinak, D. Jun, K. Musilek, F. Worek, F. Nachon, O. Soukup, J. Korabecny
- 520 9_
- $a To date, the only treatments developed for poisoning by organophosphorus compounds, the most toxic chemical weapons of mass destruction, have exhibited limited efficacy and versatility. The available causal antidotes are based on reactivation of the enzyme acetylcholinesterase (AChE), which is rapidly and pseudo-irreversibly inhibited by these agents. In this study, we developed a novel series of monoquaternary reactivators combining permanently charged moieties tethered to position 6- of 3-hydroxypyridine-2-aldoxime reactivating subunit. Highlighted representatives (21, 24, and 27; also coded as K1371, K1374, and K1375, respectively) that contained 1-phenylisoquinolinium, 7-amino-1-phenylisoquinolinium and 4-carbamoylpyridinium moieties as peripheral anionic site ligands, respectively, showed efficacy superior or comparable to that of the clinically used standards. More importantly, these reactivators exhibited wide-spectrum efficacy and were minutely investigated via determination of their reactivation kinetics in parallel with molecular dynamics simulations to study their mechanisms of reactivation of the tabun-inhibited AChE conjugate. To further confirm the potential applicability of these candidates, a mouse in vivo assay was conducted. While K1375 had the lowest acute toxicity and the most suitable pharmacokinetic profile, the oxime K1374 with delayed elimination half-life was the most effective in ameliorating the signs of tabun toxicity. Moreover, both in vitro and in vivo, the versatility of the agents was substantially superior to that of clinically used standards. Their high efficacy and broad-spectrum capability make K1374 and K1375 promising candidates that should be further investigated for their potential as nerve agents and insecticide antidotes.
- 650 _2
- $a acetylcholinesterasa $x účinky léků $x metabolismus $7 D000110
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antidota $x chemická syntéza $x chemie $x farmakologie $7 D000931
- 650 _2
- $a reaktivátory cholinesterasy $x chemická syntéza $x chemie $x farmakologie $7 D002801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 _2
- $a simulace molekulární dynamiky $7 D056004
- 650 _2
- $a oximy $x chemická syntéza $x chemie $x farmakologie $7 D010091
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Hepnarova, Vendula $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic
- 700 1_
- $a Karasova, Jana Zdarova $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic
- 700 1_
- $a Hrabinova, Martina $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic
- 700 1_
- $a Courageux, Charlotte $u Departement de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale Des Armées, 1 Place Générale Valérie André, 91220, Brétigny-sur-Orge, France
- 700 1_
- $a Dias, José $u Departement de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale Des Armées, 1 Place Générale Valérie André, 91220, Brétigny-sur-Orge, France
- 700 1_
- $a Kucera, Tomas $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic
- 700 1_
- $a Kobrlová, Tereza, $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic $d 1991- $7 xx0277928
- 700 1_
- $a Muckova, Lubica $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic
- 700 1_
- $a Prchal, Lukas $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic
- 700 1_
- $a Malinak, David $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03, Hradec Kralove, Czech Republic
- 700 1_
- $a Jun, Daniel $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic
- 700 1_
- $a Musilek, Kamil $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03, Hradec Kralove, Czech Republic
- 700 1_
- $a Worek, Franz $u Bundeswehr Institute of Pharmacology and Toxicology, Neuherbergstrasse 11, 80937, Munich, Germany
- 700 1_
- $a Nachon, Florian $u Departement de Toxicologie et Risques Chimiques, Institut de Recherche Biomédicale Des Armées, 1 Place Générale Valérie André, 91220, Brétigny-sur-Orge, France
- 700 1_
- $a Soukup, Ondrej $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic. ondrej.soukup@fnhk.cz $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic. ondrej.soukup@fnhk.cz
- 700 1_
- $a Korabecny, Jan $u Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, 500 05, Hradec Kralove, Czech Republic. jan.korabecny@fnhk.cz $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, 500 01, Hradec Kralove, Czech Republic. jan.korabecny@fnhk.cz
- 773 0_
- $w MED00009265 $t Archives of toxicology $x 1432-0738 $g Roč. 95, č. 3 (2021), s. 985-1001
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33517499 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20221024101851 $b ABA008
- 999 __
- $a ok $b bmc $g 1751879 $s 1155710
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 95 $c 3 $d 985-1001 $e 20210131 $i 1432-0738 $m Archives of toxicology $n Arch Toxicol $x MED00009265
- LZP __
- $a Pubmed-20220113